NCT01369602
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site DeLand, Florida, United States